Gerhard works at UC Davis, based in California, and has been established there since 2006. Here he has been directing the UC Davis GMP facility, which opened in February of 2010. Over the last 8 years, several novel manufacturing technologies for gene therapy vectors have also been pioneered in this facility. The UC Davis GMP facility currently manufactures products for eight clinical trials conducted in several centers nationwide.